Cyclin dependent kinases in cancer: potential for therapeutic intervention

Cancer Biology & Therapy
Miriam CanaveseNoopur Raje

Abstract

Cell cycle progression through each phase is regulated by heterodimers formed by cyclin-dependent kinases (CDKs) and their regulatory partner proteins, the cyclins. Together they coordinate the cellular events through cell cycle. De-regulation of cell-cycle control due to aberrant CDK activity is a common feature of most cancer types. Intensive research on small molecules that target cell cycle regulatory proteins has led to the identification of many candidate inhibitors that are able to arrest proliferation and induce apoptosis in neoplastic cells as a promising strategy to treat cancer. Interestingly, cyclin-dependent kinases (CDKs) have also been proposed as therapeutic targets for Multiple Myeloma (MM). Overexpression and aberrant expression of the cyclins, specifically the D cyclins is seen in the majority of MM underscoring the value of exploring CDK inhibition in MM which currently remains an incurable neoplastic plasma-cell disorder. It is characterized by clonal proliferation of malignant plasma cells in the bone marrow microenviroment and associated organ dysfunction. Recent preclinical and early clinical data explore several CDK inhibitors in the context of MM. This review will provide an overview of the main classe...Continue Reading

References

Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M SenderowiczE A Sausville
Jun 17, 2000·Investigational New Drugs·A MonksE A Sausville
Sep 19, 2000·Nature·S AkoulitchevD Reinberg
Apr 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G K SchwartzD Kelsen
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E A SausvilleA M Senderowicz
Jan 25, 2002·Journal of Cellular Physiology·Thomas Oelgeschläger
Apr 3, 2002·Trends in Molecular Medicine·Edward A Sausville
Apr 19, 2002·Biochimica Et Biophysica Acta·Sagrario OrtegaMariano Barbacid
Nov 27, 2002·Cancer Chemotherapy and Pharmacology·James P ThomasGeorge Wilding
Apr 5, 2003·Cancer Cell·Osamu Tetsu, Frank McCormick
Jun 18, 2003·Accounts of Chemical Research·Laurent Meijer, Eric Raymond
Jul 26, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AkliluE E Vokes
Aug 19, 2003·Nature Genetics·Sagrario OrtegaMariano Barbacid
Aug 28, 2003·Cell·Yan GengPiotr Sicinski
Sep 25, 2003·Cell Cycle·M Saeed Sheikh, Ying Huang
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Glenn LiuGeorge Wilding
Apr 20, 2004·Blood·Teru HideshimaKenneth C Anderson
Apr 23, 2004·Trends in Biochemical Sciences·Richard S Jope, Gail V W Johnson
May 4, 2004·Investigational New Drugs·Susan Burdette-RadouxElizabeth A Eisenhauer
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy KortmanskyGary K Schwartz
Apr 20, 2005·Oncogene·Amit DeshpandePhilip W Hinds
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manish A ShahGary K Schwartz
Jun 21, 2005·Current Opinion in Pharmacology·Ian Collins, Michelle D Garrett
Jul 27, 2005·Seminars in Cancer Biology·Kelly K Hunt, Khandan Keyomarsi
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Keith C BibleCharles Erlichman
Sep 9, 2005·Frontiers in Bioscience : a Journal and Virtual Library·David Santamaria, Sagrario Ortega
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P Leif Bergsagel, W Michael Kuehl
Oct 21, 2005·Trends in Biochemical Sciences·Marcos Malumbres, Mariano Barbacid
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary K Schwartz, Manish A Shah
Apr 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey I Shapiro
Aug 5, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G SiemeisterKlaus Bosslet
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M N FornierG K Schwartz
Feb 13, 2008·Developmental Cell·Arnaud BessonJames M Roberts
Jul 22, 2008·Drug Discovery Today·Campbell McInnes
Sep 16, 2008·Molecular Cancer Therapeutics·Karima BettayebLaurent Meijer
Mar 6, 2009·Investigational New Drugs·Ivan Diaz-PadillaIgnacio Duran

❮ Previous
Next ❯

Citations

Aug 27, 2013·Biochemical Pharmacology·Marie-Hélène TeitenMarc Diederich
Dec 12, 2012·Journal of Proteome Research·Terry FarrahRobert L Moritz
Mar 8, 2013·Future Microbiology·Abhik Saha, Erle S Robertson
Aug 27, 2013·Cellular and Molecular Life Sciences : CMLS·Robert J Huber
Dec 24, 2013·Pharmacology & Therapeutics·Todd M PittsErica L Bradshaw-Pierce
Jul 2, 2014·Medical Oncology·Jing MaYafei Wang
Aug 12, 2014·European Journal of Medicinal Chemistry·Felicia Phei Lin Lim, Anton V Dolzhenko
May 1, 2013·Biochemistry·Stephan C JahnBrian K Law
Dec 27, 2013·Expert Opinion on Pharmacotherapy·Andrea RoccaDino Amadori
Sep 13, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gaëlle Mariaule, Philippe Belmont
May 14, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hye Young ParkYung Hyun Choi
Feb 10, 2016·Breast Cancer Research : BCR·Richard S FinnDennis J Slamon
Nov 29, 2015·Seminars in Oncology·Loredana SantoNoopur Raje
Jun 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Mehmet Topcul, Idil Cetin
Jan 7, 2014·Biochimica Et Biophysica Acta·Jaclyn E QuinRoss D Hannan
Feb 15, 2013·Pharmaceutical Biology·Orathai UadklaWilart Pompimon
May 20, 2015·Lung·Elżbieta Radzikowska
Jan 9, 2014·Radiation Research·Constantinos G Broustas, Howard B Lieberman
Dec 4, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Hyun Soo ParkYung Hyun Choi
Apr 26, 2014·Blood·Theresa PlackeStefan Fröhling
Jun 4, 2013·Journal of Theoretical Biology·Sunil Kumar TripathiSanjeev Kumar Singh
Aug 20, 2014·PloS One·Jasmina MakarevićRoman A Blaheta
Jul 7, 2016·Nucleic Acids Research·Giancarlo BaroneSpencer J Collis
Apr 10, 2018·Chemical Communications : Chem Comm·Clement Opoku-TemengHerman O Sintim
Feb 24, 2018·Scientific Reports·Andrana Karla CalgarottoSara Teresinha Olalla Saad
Dec 6, 2018·Current Drug Targets·Priscylla Andrade VolkartWalter Filgueira de Azevedo
Sep 4, 2019·Cancer Gene Therapy·Abbas AbiSeyed Mohammad Gheibi Hayat
Jul 20, 2016·International Journal of Molecular Medicine·Rui-Ting LiuXiao-Qiang Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.